Skip to main content
. 2019 Nov 24;12(11):e231044. doi: 10.1136/bcr-2019-231044

Table 1.

Initial tests on admission

Test (unit) Result (range)
PT (s) 13.3 (9.8–14.6)
PLT (x109/L) 198 (150–450)
Albumin (g/L) 35 (35–50)
ALT (IU/L) 96 (1–34)*
AST (IU/L) 141 (12–34)*
Bilirubin (μmol/L) 50 (3–21)*
GGT (IU/L) 908 (0–37)*
ALP (IU/L) 955 (30–130)*
IgG (g/L) 14.5 (6–16)
IgA (g/L) 4.9 (0.8–4)
IgM (g/L) 1.3 (0.5–2)
ANA 1:160, speckled*
Anti-DNA (IU/mL) 1 (0–15)
Anti-ENA -ve
AMA -ve
ASMA -ve
Anti-GPC -ve
Anti LKM-1 -ve
Hepatitis B -ve
Hepatitis C -ve
HIV -ve
CMV -ve
EBV -ve
AFP (kU/L) 3 (0–7)
CA-125 (kU/L) 1632 (0–35)*

*Abnormal results.

AFP, Alphafetoprotein; ALT, Alanine Aminotransferase; ANA, Anti Nuclear Antibodies; ASMA, Anti Smooth Muscle Antibodies; AST, Aspartate Aminotransferase; CMV, Cytomegalovirus; ENA, Extractable Nuclear Antigen; GGT, Gamma-glutamyl Transferase; GPC, Gastric Parietal Cell; LKM-1, Anti Liver Kidney Microsomal type 1 antibody; PLT, Platelet Count; PT, Prothrombin Time.